logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
25/09/2025
Spanish Prime Minister Sanchez: Spain needs to address the housing problem.
Latest
9 m ago
Insiders say that Rwanda and Congo aim to complete the relevant measures by the end of the year. Actions against the Democratic Forces for the Liberation of Rwanda and the lifting of Rwandan defensive measures will begin at the end of October.
12 m ago
A small plane crashed in Venezuela and two people were rescued.
13 m ago
Boston - (U.S. Business Information) - September 24, 2025 - PepGen Inc. (NASDAQ: PEPG) is a clinical-stage biotechnology company developing next-generation oligonucleotide therapies aimed at changing the treatment of severe neuromuscular and neurological diseases. The company announced today positive clinical data from the 15 mg/kg dose cohort of the ongoing FREEDOM-DM1 Phase 1 Single Ascending Dose (SAD) study in patients with myotonic dystrophy (DM1). These latest results show that the average splicing correction rate after a single dose of 15 mg/kg of PGN-EDODM1 is 53.7%, significantly higher than previously reported splicing correction in DM1 patients.
18 m ago
Air Canada: The financial impact caused by the labor dispute is expected to reduce operating income and adjusted earnings before interest, taxes, depreciation, and amortization by $375 million.
19 m ago
Air Canada's outlook for 2025: Capacity is expected to increase by 0.5% to 1.5% compared to 2024.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.